RU2011116948A - METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR - Google Patents
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR Download PDFInfo
- Publication number
- RU2011116948A RU2011116948A RU2011116948/15A RU2011116948A RU2011116948A RU 2011116948 A RU2011116948 A RU 2011116948A RU 2011116948/15 A RU2011116948/15 A RU 2011116948/15A RU 2011116948 A RU2011116948 A RU 2011116948A RU 2011116948 A RU2011116948 A RU 2011116948A
- Authority
- RU
- Russia
- Prior art keywords
- growth factor
- endothelial dysfunction
- antibody
- correction
- vascular endothelium
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к фактору роста сосудистого эндотелия, отличающийся тем, что в эксперименте крысам самцам линии Wistar в течение 28 дней, на фоне внутрибрюшинного введения L-Name в дозе 12,5 мг/кг, ежедневно, 2 раза в сутки по 4,5 мл/кг (9 мл/кг/сут), внутрижелудочно, вводят смесь растворов гомеопатических разведении моноклональных антител к фактору роста сосудистого эндотелия (VEGF) - С12, С30, С200. A method for correcting endothelial dysfunction with a solution of homeopathic dilutions of antibodies to vascular endothelial growth factor, characterized in that in the experiment, rats of Wistar males for 28 days, against the background of intraperitoneal administration of L-Name at a dose of 12.5 mg / kg, daily, 2 times a day at 4.5 ml / kg (9 ml / kg / day), intragastrically, a mixture of solutions of homeopathic dilution of monoclonal antibodies to vascular endothelial growth factor (VEGF) is administered - C12, C30, C200.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011116948/15A RU2526151C2 (en) | 2011-04-28 | 2011-04-28 | Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011116948/15A RU2526151C2 (en) | 2011-04-28 | 2011-04-28 | Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011116948A true RU2011116948A (en) | 2012-11-10 |
RU2526151C2 RU2526151C2 (en) | 2014-08-20 |
Family
ID=47321874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011116948/15A RU2526151C2 (en) | 2011-04-28 | 2011-04-28 | Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2526151C2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007067807A1 (en) * | 2005-12-07 | 2007-06-14 | Alacrity Biosciences, Inc. | Tetracyclines for treating ocular diseases and disorders |
-
2011
- 2011-04-28 RU RU2011116948/15A patent/RU2526151C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2526151C2 (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20190262A1 (en) | METHODS FOR TREATING CANCER BY USE OF PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS | |
RS52452B (en) | Antibodies and immunoconjugates and uses thereof | |
PE20142167A1 (en) | ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES | |
PE20150025A1 (en) | ANTIBODIES AND IMMUNOCONJUGATES AGAINST LY6E AND METHODS OF USE | |
MX2018012648A (en) | Antibody-containing preparation. | |
AR096364A1 (en) | ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE | |
UA116189C2 (en) | FORMULATION FOR ANTI-α4β7 ANTIBODY | |
EA201792652A3 (en) | NEW DERIVATIVES OF MAYTANZINOIDS WITH PEPTIDE LINKER AND THEIR CONJUGATES | |
PE20181009A1 (en) | ANTI-HtrA1 ANTIBODIES AND METHODS OF USE OF THEM | |
PE20141413A1 (en) | ANTIBODY FORMULATIONS AND METHODS | |
PE20120899A1 (en) | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B | |
PE20142170A1 (en) | ANTIBODIES AGAINST BRADYCININ B1 RECEPTOR LIGANDS | |
PE20120080A1 (en) | ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE | |
RU2015102069A (en) | ANTIBODIES TO BIOTIN AND WAYS OF THEIR APPLICATION | |
MX359263B (en) | Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease. | |
EA201490756A1 (en) | CITRAMID RAZAGLININA | |
PE20141706A1 (en) | TROMBINA UNION ANTIBODIES AND USES OF THE SAME | |
JP2013535483A5 (en) | ||
RU2011116948A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR | |
RU2011116945A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODIES HOMEOPATHIC DILUTION TO TUMOR-ALPHA NECROSIS FACTOR | |
RU2011116946A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-1 | |
RU2011116949A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE | |
PE20131328A1 (en) | ANTI-VEGFR-3 ANTIBODY COMPOSITIONS | |
RU2011116947A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO THE C-END Fragment of the Angiotensin II Receptor | |
RU2011116944A (en) | METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130116 |
|
FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20140116 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20150429 |